MedPath

Alprazolam

ALPRAZOLAM TABLETS, USP0.25 mg, 0.5 mg, 1 mg and 2 mg

Approved
Approval ID

0d97256b-77f5-405e-b5be-cded19653180

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 13, 2012

Manufacturers
FDA

Dispensing Solutions, Inc.

DUNS: 066070785

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

alprazolam

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code66336-932
Application NumberANDA078491
Product Classification
M
Marketing Category
C73584
G
Generic Name
alprazolam
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 13, 2012
FDA Product Classification

INGREDIENTS (9)

ALPRAZOLAMActive
Quantity: 1 mg in 1 1
Code: YU55MQ3IZY
Classification: ACTIB
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
DOCUSATE SODIUMInactive
Code: F05Q2T2JA0
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EU
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT

Drug Labeling Information

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 12/5/2011

Manufactured for:
QUALITEST PHARMACEUTICALS
Huntsville, AL 35811

8182238
R11/11-R4

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Alprazolam - FDA Drug Approval Details